Company Search:
Advanced Search
Sponsored Links
Bavarian Nordic AS - ADR Company Snapshot
Bavarian Nordic AS operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bavarian Nordic AS with three other companies in this sector in the United States: Momenta Pharmaceuticals, Inc. (2018 sales of $75.59 million of which 100% was Drug Products), Sangamo Therapeutics Inc ($84.45 million of which 100% was Research & Colloboration), and Xtant Medical Holdings Inc ($72.20 million of which 68% was Orthobiologics).

Sales Analysis. Bavarian Nordic AS reported sales of $79.13 million for the year ending December of 2018. This represents a sharp decrease of 62.3% versus 2017, when the company's sales were $209.82 million.
  Stock Performance Chart for Bavarian Nordic AS - ADR
  Stock Data: Recent Stock Performance:
  Current Price (1/16/2020): 9.31
(Figures in U.S. Dollars)
1 Week n/a   13 Weeks 12.8%  
4 Weeks 5.4%   52 Weeks 22.5%  
Bavarian Nordic AS - ADR Key Data:
  Ticker: BVNRY Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 79,132,529
(Year Ending Jan 2019).
Employees: 419
  Currency: U.S. Dollars Market Cap: 902,572,125
  Fiscal Yr Ends: December Shares Outstanding: 96,946,523
  Share Type: Common Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.